logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
U

Ulrike Nitz

west german study group
H指数:39
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A tale of two trials: TAILORx and PlanB. Letter to the Editor regarding “Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/ HER2-negative breast cancer” by Chen et al.

两种试验的故事：TAILORx和PlanB。关于Chen等人撰写的“基因组高风险、淋巴结阴性、HR阳性/HER2阴性乳腺癌中蒽环类药物的影响”一文的致编辑函。

Annals of Oncology
IF65.4
2025-12-200
PRE
Oleg Gluz; Ronald Kates; Sherko Kuemmel; Ulrike Nitz; Nadia Harbeck
Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry

激素受体阳性早期乳腺癌患者参与WSG PlanB试验并在基因表达分析预筛选后的长期结局数据：WSG PlanB登记研究的10年生存结果

ESMO Open
IF8.3
2025-11-270
OAAI
U. Nitz; M. Graeser; O. Gluz; S. Kümmel; M. Just; C. Jackisch; C. zu Eulenburg; M. Christgen; N. Harbeck
The Janus Face of SPAG6: Inducing EMT in Luminal Breast Cancer Cells Amidst Widespread Expression Loss in Breast Tumours

SPAG6的两面性：在乳腺肿瘤中SPAG6表达广泛缺失的背景下，诱导乳腺导管癌细胞发生EMT

Journal of Cellular and Molecular Medicine
IF4.2
2025-10-090
OAAI
Antonio Sechi; Jolein Mijnes; Sophia Villwock; Michael Rose; Florian Steib; Sarah Bringezu; Jonas Berger; Carmen Schalla; Sonja von Serenyi; Jana Dietrich; Nadina Ortiz-Brüchle; Lara Heij; Jan Bednarsch; Oleg Gluz; Ulrike Nitz; Nadia Harbeck; Monika Graeser; Christine zu Eulenburg; Mohammad Parsa Mohammadian; Katarzyna Jóźwiak; Hans-Heinrich Kreipe; Matthias Christgen; Martin Radner; Danny Jonigk; Edgar Dahl
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders

一个预测性内分泌抵抗指数能够准确地对腔面型乳腺癌治疗反应者和非反应者进行分层。

JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2025-10-012
OA
Zhang, Guokun; Jurinovic, Vindi; Bartels, Stephan; Christgen, Matthias; Christgen, Henriette; Kandt, Leonie Donata; Mishieva, Lidiya; Ni, Hua; Raap, Mieke; Klein, Janin; Katzke, Anna-Lena; Hofmann, Winfried; Steinemann, Doris; Kates, Ronald E.; Gluz, Oleg; Graeser, Monika; Kummel, Sherko; Nitz, Ulrike; Plass, Christoph; Lehmann, Ulrich; Eulenburg, Christine zu; Mansmann, Ulrich; Gerhauser, Clarissa; Harbeck, Nadia; Kreipe, Hans H.
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)

内分泌反应评估在HR阳性HER2阴性早期乳腺癌中的应用：WSG ADAPTcycle试验（n=5292）中局部与中央Ki67测量的符合情况

ESMO Open
IF8.3
2025-08-140
OAAI
M. Hamann; M. Christgen; O. Gluz; U. Nitz; S. Kuemmel; M. Braun; M. Thill; R. Wuerstlein; P. Wimberger; A. Hartkopf; C. Schem; M. Zaiss; V. Bjelic-Radisic; M. Just; K. Veselinovic; M. Vincent; M. Graeser; K. Krauss; O. Hoffmann; K. Lüdtke-Heckenkamp; R.E. Kates; C. zu Eulenburg; K. Jóźwiak; S. Burmeister; M. Hauptmann; F. Baehner; P. Schmid; H.-H. Kreipe; N. Harbeck
Prediction of survival after de-escalated neoadjuvant therapy in HER2+ early breast cancer: A pooled analysis of three WSG trials

HER2+早期乳腺癌降级新辅助治疗后生存预测：一项基于三项WSG试验的合并分析

Annals of Oncology
IF65.4
2025-08-050
PREAI
M. Graeser; O. Gluz; C. Zu Eulenburg; S. Kuemmel; R. von Schumann; M. Christgen; R. Wuerstlein; E. Pelz; H.H. Kreipe; P. Schmid; M. Thill; M. Braun; J. Potenberg; C. Schumacher; J. Tio; J. Schumacher; L. Wujak; A.D. Hartkopf; M. Just; C. Schem; K. Luedtke-Heckenkamp; F. Hilpert; A. Kentsch; R.E. Kates; U. Nitz; N. Harbeck
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

免疫调节基因网络预测在WSG-ADAPT-TN试验中，三阴性乳腺癌对降级、无蒽环类的新辅助化疗的治疗反应和生存情况。

MOLECULAR CANCER
IF33.9
2025-03-260
OA
Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J.; Trau, Matt; Graeser, Monika; Harbeck, Nadia
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer A Secondary Analysis of a Randomized Clinical Trial

三阴性乳腺癌患者中的基因改变、治疗反应和生存情况：一项随机临床试验的二次分析

JAMA NETWORK OPEN
IF9.7
2025-02-260
OA
Richters, Lisa; Gluz, Oleg; Weber-Lassalle, Nana; Christgen, Matthias; Haverkamp, Heinz; Kuemmel, Sherko; Kayali, Mohamad; Kates, Ronald E.; Grischke, Eva-Maria; Altmueller, Janine; Forstbauer, Helmut; Thiele, Holger; Braun, Michael; Warm, Mathias; Ossowski, Anna; Wuerstlein, Rachel; Ernst, Corinna; Graeser, Monika; Linn, Sabine C.; Nitz, Ulrike; Hauke, Jan; Kreipe, Hans Heinrich; Schmutzler, Rita K.; Hahnen, Eric; Harbeck, Nadia
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
BREAST CANCER RESEARCH
IF5.6
2025-02-140
OAAI
Schmidt, Gilda; Gluz, Oleg; Christgen, Matthias; Reinisch, Mattea; Kuemmel, Sherko; Nitz, Ulrike; Braun, Michael; Aktas, Bahriye; Luedtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Mahlberg, Rolf; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Stefek, Andrea; Wuerstlein, Rachel; Graeser, Monika; Jozwiak, Katarzyna; Burmeister, Sandy; zu Eulenburg, Christine; Lauseker, Michael; Kolberg-Liedtke, Cornelia; Prat, Aleix; Schmid, Peter; Baehner, Rick; Kreipe, Hans Heinrich; Solomayer, Erich-Franz; Harbeck, Nadia; West German Study Grp Investigators
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

早期三阴性乳腺癌经新辅助紫杉烷类药物治疗后的TNBC-DX基因组检测

ANNALS OF ONCOLOGY
IF65.4
2025-02-014
OAAI
Martin, M.; Stecklein, S. R.; Gluz, O.; Villacampa, G.; Monte-Millan, M.; Nitz, U.; Cobo, S.; Christgen, M.; Braso-Maristany, F.; Alvarez, E. L.; Echavarria, I.; Conte, B.; Kuemmel, S.; Bueno-Muino, C.; Jerez, Y.; Kates, R.; Cebollero, M.; Kolberg-Liedtke, C.; Bueno, O.; Garcia-Saenz, J. a.; Moreno, F.; Grischke, E. -m.; Forstbauer, H.; Braun, M.; Warm, M.; Hackmann, J.; Uleer, C.; Aktas, B.; Schumacher, C.; Wuerstleins, R.; Graeser, M.; zu Eulenburg, C.; Kreipe, H. H.; Gomez, H.; Massarrah, T.; Herrero, B.; Pare, L.; Bohn, U.; Lopez-Tarruella, S.; Vivanco, A.; Sanfeliu, E.; Parker, J. S.; Perou, C. M.; Villagrasa, P.; Prat, A.; Sharma, P.; Harbeck, N.
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy

TNBC-DX基因组检测在未接受免疫治疗的早期三阴性乳腺癌患者中的应用，该患者接受新辅助紫杉烷类药物治疗

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Martin Jimenez, M.; Gluz, O.; Villacampa, G.; Lopez-Tarruella Cobo, S.; Nitz, U. A.; Cobo, S.; Braso-Maristany, F.; Christgen, M.; Jerez Gilarranz, Y.; Kummel, S.; Conte, B.; Diaz-Guardamino, I. Echavarria; Graeser-Mayer, M. K.; Kreipe, H.; Del Monte-Millan, M.; Herrero Lopez, B.; Perou, C. M.; Pare Brunet, L.; Prat, A.; Harbeck, N.
Survival outcome of neoadjuvant endocrine therapy plus trastuzumab and pertuzumab (ET plus T plus P) vs. de-escalated chemotherapy (CT) plus T plus P in hormone receptor positive (HR+)/HER2+early breast cancer (EBC): WSG-TP-II trial

内分泌新辅助治疗联合曲妥珠单抗和帕妥珠单抗（ET plus T plus P）与降级化疗（CT）联合曲妥珠单抗和帕妥珠单抗（T plus P）在激素受体阳性（HR\(+\)/HER2\(+\)）早期乳腺癌（EBC）中的生存结局：WSG-TP-II试验

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Gluz, O.; Nitz, U. A.; Christgen, M.; Kummel, S.; Holtschmidt, J.; Schumacher, J.; Hartkopf, A. D.; Luedtke-Heckenkamp, K.; Just, M.; von Schumann, R.; Polata, S.; Schinkoethe, T.; Graeser-Mayer, M. K.; Kates, R. E.; Wuerstlein, R.; Kreipe, H.; Harbeck, N.
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium
MODERN PATHOLOGY
IF5.5
2024-07-015
OAAI
De Schepper, Maxim; Koorman, Thijs; Richard, Francois; Christgen, Matthias; Vincent-Salomon, Anne; Schnitt, Stuart J.; van Diest, Paul J.; Zels, Gitte; Mertens, Freya; Maetens, Marion; Vanden Bempt, Isabelle; Harbeck, Nadia; Nitz, Ulrike; Graser, Monika; Kuemmel, Sherko; Gluz, Oleg; Weynand, Birgit; Floris, Giuseppe; Derksen, Patrick W. B.; Desmedt, Christine
Individual patient data meta-analysis of clinical and translational biomarkers for prediction of pathological complete response (pCR) after de-escalated therapy in HER2+breast cancer in four trials of the West German Study Group
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Graeser, Monika; Gluz, Oleg; zu Eulenburg, Christine; Kuemmel, Sherko; von Schumann, Raquel; Christgen, Matthias; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans-Heinrich; Schmid, Peter; Thill, Marc; Braun, Michael; Potenberg, Jochem; Schumacher, Claudia; Tio, Joke; Hartkopf, Andreas; Just, Marianne; Schem, Christian; Ludtke-Heckenkamp, Kerstin; Grischke, Eva-Maria; Hilpert, Felix; Kentsch, Angela; Kates, Ronald; Nitz, Ulrike; Harbeck, Nadia
Multi-modal artificial intelligence models from baseline histopathology predict prognosis in HR+HER2-early breast cancer
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Kates-Harbeck, Daniel; Kreipe, Hans-Heinrich; Gluz, Oleg; Christgen, Matthias; Kuemmel, Sherko; Graeser, Monika; Nitz, Ulrike; Mahner, Sven; Mayr, Doris; Wuerstlein, Rachel; Mitani, Akinori; Zhang, Jingbin; Pinckaers, Hans; Ren, Yi; Wood, Peter; Griffin, Jacqueline; Feng, Felix; Esteva, Andre; Keim-Malpass, Jess; Kates, Ronald; Harbeck, Nadia
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; zu Eulenburg, Christine; Jozwiak, Katarzyna; Burmeister, Sandy; Baehner, Rick; Schmid, Peter; Kreipe, Hans-Heinrich; Harbeck, Nadia
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter WSG-ADAPTcycle trial (n=5,290)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; Eulenburg, Christine Zu; Schmid, Peter; Baehner, Rick; Kreipe, Hans-Heinrich; Harbeck, Nadia
HER2DX genomic assay in triple-negative breast cancer (TNBC) patients treated with 12-weeks of neoadjuvant chemotherapy: a correlative analysis from WSGADAPT-TN phase II trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Braso-Maristany, Fara; Nitz, Ulrike; Pare, Laia; Christgen, Matthias; Villacampa, Guillermo; Conte, Benedetta; Kuemmel, Sherko; Kates, Ronald; Kolberg-Liedtke, Cornelia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Vivancos, Ana; Wuerstlein, Rachel; Parker, Joel S.; Graeser, Monika; Perou, Charles M.; zu Eulenburg, Christine; Villagrasa, Patricia; Kreipe, Hans-Heinrich; Prat, Aleix; Harbeck, Nadia
Circulating tumor DNA (ctDNA) for prediction of pathologic complete response (pCR) after 12 weeks of pembrolizumab plus trastuzumab plus pertuzumab in HER2-enriched early breast cancer: WSG-Keyriched-1 trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Graeser, Monika; Kuemmel, Sherko; Gluz, Oleg; Schroeder, Christopher; Schuetz, Leon; Kelemen, Olga; Ossowski, Stephan; Jozwiak, Katarzyna; Reinisch, Mattea; Kostara, Athina; Scheffen, Iris; Ludtke-Heckenkamp, Kerstin; Hilpert, Felix; Kentsch, Angela; Ziske, Carsten; Depenbusch, Reinhard; Braun, Michael; Blohmer, Jens-Uwe; Christgen, Matthias; Bartels, Stephan; Kreipe, Hans-Heinrich; Pelz, Enrico; Nitz, Ulrike; Schmid, Peter; Harbeck, Nadia; Hartkopf, Andreas

研究方向

暂未获取到该数据
N
Nadia Harbeck
H 指数:131论文数:2,063被引数:8.5万
O
Oleg Gluz
H 指数:38论文数:417被引数:6,724
M
Matthias Christgen
H 指数:38论文数:245被引数:5,349
R
Ronald Kates
H 指数:42论文数:357被引数:6,721
R
Rachel Wuerstlein
H 指数:38论文数:475被引数:5,749
M
Michael Braun
H 指数:46论文数:388被引数:8,311
B
Bahriye Aktas
H 指数:42论文数:511被引数:8,707
H
Hans Kreipe
H 指数:78论文数:712被引数:2.4万
S
Sherko Küemmel
H 指数:33论文数:234被引数:5,350
H
Helmut Forstbauer
H 指数:23论文数:180被引数:2,555